Arora, S., Sasaki, K., Short, N., Jain, N., Ravandi, F., Haddad, F., Senapati, J., Montalban-Bravo, G., Bazinet, A., Khouri, R., Garris, R., Kantarjian, H., Jabbour, E. (2025). Risk factors for relapse and post-relapse outcomes in patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia receiving frontline blinatumomab-based regimens. Blood. https://doi.org/10.1182/blood-2025-759